1. Home
  2. VECO vs NVAX Comparison

VECO vs NVAX Comparison

Compare VECO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VECO
  • NVAX
  • Stock Information
  • Founded
  • VECO 1945
  • NVAX 1987
  • Country
  • VECO United States
  • NVAX United States
  • Employees
  • VECO N/A
  • NVAX N/A
  • Industry
  • VECO Industrial Machinery/Components
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VECO Technology
  • NVAX Health Care
  • Exchange
  • VECO Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • VECO 1.4B
  • NVAX 1.3B
  • IPO Year
  • VECO 1994
  • NVAX 1995
  • Fundamental
  • Price
  • VECO $27.15
  • NVAX $8.39
  • Analyst Decision
  • VECO Buy
  • NVAX Buy
  • Analyst Count
  • VECO 6
  • NVAX 7
  • Target Price
  • VECO $27.33
  • NVAX $14.29
  • AVG Volume (30 Days)
  • VECO 930.7K
  • NVAX 6.8M
  • Earning Date
  • VECO 11-05-2025
  • NVAX 11-11-2025
  • Dividend Yield
  • VECO N/A
  • NVAX N/A
  • EPS Growth
  • VECO N/A
  • NVAX N/A
  • EPS
  • VECO 1.02
  • NVAX 2.54
  • Revenue
  • VECO $700,334,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • VECO N/A
  • NVAX $61.69
  • Revenue Next Year
  • VECO $8.48
  • NVAX N/A
  • P/E Ratio
  • VECO $26.48
  • NVAX $3.30
  • Revenue Growth
  • VECO N/A
  • NVAX 9.22
  • 52 Week Low
  • VECO $16.92
  • NVAX $5.01
  • 52 Week High
  • VECO $34.34
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • VECO 71.17
  • NVAX 56.61
  • Support Level
  • VECO $24.52
  • NVAX $7.83
  • Resistance Level
  • VECO $25.96
  • NVAX $8.31
  • Average True Range (ATR)
  • VECO 0.75
  • NVAX 0.38
  • MACD
  • VECO 0.17
  • NVAX 0.05
  • Stochastic Oscillator
  • VECO 92.98
  • NVAX 74.84

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: